Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19
Clinical trial NCT05165732 · SUSPENDED
Trial details
- NCT number
- NCT05165732
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-20
- Primary completion
- 2023-03-20
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.